Holen Sie sich die Stockscreener-App
27.85
2.01%
0.55
Handel nachbörslich:
27.85
Schlusskurs vom Vortag:
$27.30
Offen:
$27.65
24-Stunden-Volumen:
248.67K
Relative Volume:
0.81
Marktkapitalisierung:
$1.63B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.87%
1M Leistung:
+14.00%
6M Leistung:
+90.10%
1J Leistung:
+0.00%
1-Tages-Spanne:
$26.24
$28.10
1-Wochen-Bereich:
$24.35
$28.10
52-Wochen-Spanne:
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
27.85 | 1.59B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | BTIG Research | Buy |
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
Kestra Medical Technologies (KMTS) Investor Outlook: 53% Revenue Surge and 8% Upside Potential - DirectorsTalk Interviews
Bullish Kestra Medical Technologies Insiders Loaded Up On US$858.5k Of Stock - simplywall.st
Kestra Medical Technologies (KMTS) Stock Analysis: Exploring A 16% Potential Upside - DirectorsTalk Interviews
Kestra Medical Technologies reports strong earnings growth - MSN
Market Leaders: Is Kestra Medical Technologies Ltd stock forming a cup and handleStop Loss & Consistent Income Trade Recommendations - baoquankhu1.vn
Can Kestra Medical Technologies Ltd. reach all time highs this yearQuarterly Portfolio Review & Weekly High Return Forecasts - mfd.ru
Is Kestra Medical Technologies Ltd. stock forming a cup and handleWeekly Stock Analysis & High Accuracy Trade Signal Alerts - mfd.ru
Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Promising 16.84% Upside in the Healthcare Sector - DirectorsTalk Interviews
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) versus Envista (NYSE:NVST) Head to Head Analysis - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpShould You Buy? - MarketBeat
Published on: 2026-01-21 23:54:20 - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares - Defense World
Short Interest in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Rises By 21.5% - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Sees Large Growth in Short Interest - MarketBeat
Should value investors consider Kestra Medical Technologies Ltd.July 2025 Trade Ideas & Weekly High Return Forecasts - bollywoodhelpline.com
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Atea Pharmaceuticals (AVIR) and Penumbra (PEN) - The Globe and Mail
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery - TradingView
Kestra Medical Technologies, Biobeat Technologies to Collaborate - Diagnostic and Interventional Cardiology
Kestra Medical partners with Biobeat to add blood pressure monitoring By Investing.com - Investing.com Nigeria
KMTS: Strong clinical data and innovation drive rapid growth and margin expansion in the WCD market - TradingView
Kestra Medical partners with Biobeat to add blood pressure monitoring - Investing.com
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery - GlobeNewswire
Kestra Medical Technologies to Invest $5 Million in Biobeat Technologies, Incorporate Diagnostic Partnership - marketscreener.com
Market Rankings: Will Kestra Medical Technologies Ltd outperform its industry peersPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6% – What’s Next? - Defense World
Goldman Sachs Maintains Kestra Medical Technologies(KMTS.US) With Hold Rating, Raises Target Price to $27 - 富途牛牛
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6%Time to Sell? - MarketBeat
Is Kestra Medical Technologies Ltd. stock positioned for long term growthEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru
Will Kestra Medical Technologies Ltd. stock return to pre crisis levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth and 19% Potential Upside - directorstalkinterviews.com
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6.1% – Here’s Why - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6.1%Here's What Happened - MarketBeat
Traci Umberger Sells 10,500 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Brian Daniel Webster Sells 15,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Webster, Kestra medical CEO, sells $398k in shares By Investing.com - Investing.com Australia
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 10,500 Shares of Stock - MarketBeat
Kestra Medical Technologies Insider Sold Shares Worth $280,201, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies Insider Sold Shares Worth $398,847, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $398,850.00 in Stock - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Both Private Equity Firms Who Control a Good Portion of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Along With Institutions Must Be Dismayed After Last Week's 3.1% Decrease - 富途牛牛
Biobeat Technologies Ltd. announced that it has received $50 million in funding from Ally Bridge Group, OrbiMed Advisors LLC, Elevage Medical Technologies, Kestra Medical Technologies, Ltd. and other investors - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Can Kestra Medical Technologies Ltd. stock maintain operating margins2025 Volume Leaders & AI Driven Stock Reports - Улправда
Will Kestra Medical Technologies Ltd. stock benefit from AI adoptionJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Es liegen keine Finanzdaten für Kestra Medical Technologies Ltd (KMTS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):